Literature DB >> 16557439

[Carbon monoxide: toxic molecule with antiinflammatory and cytoprotective properties].

P Schober1, A Koch, K Zacharowski, S A Loer.   

Abstract

Carbon monoxide arises during incomplete combustion of organic material, is incorporated into the circulation via the lungs and displaces oxygen from hemoglobin. Consecutively, symptoms of intoxication such as headache, vertigo, nausea, seizures and coma may result in a dose dependent fashion. Carbon monoxide is however also generated endogenously during heme degradation catalysed by heme oxgenase enzymes. The isoform hemeoxygenase-1 is inducible by oxidative stress and may mediate cytoprotection mainly attributable to endogenously produced carbon monoxide. Exogenous applied carbon monoxide has also been shown to confer protection in experimental studies. Meanwhile, in addition to the toxicological properties, antiinflammatory and cytoprotective effects of carbon monoxide have moved into the focus of scientific interest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557439     DOI: 10.1055/s-2006-925109

Source DB:  PubMed          Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther        ISSN: 0939-2661            Impact factor:   0.698


  3 in total

1.  Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3).

Authors:  Clara Di Filippo; Mauro Perretti; Francesco Rossi; Franca Ferraraccio; Roberto Motterlini; Michele D'Amico
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-22       Impact factor: 3.000

2.  Changes in arterial oxygen tension correlate with changes in end-expiratory carbon monoxide level.

Authors:  Patrick Schober; Melanie Kalmanowicz; Lothar A Schwarte; Joerg Weimann; Stephan A Loer
Journal:  J Clin Monit Comput       Date:  2007-02-15       Impact factor: 2.502

Review 3.  Bench-to-bedside review: Carbon monoxide--from mitochondrial poisoning to therapeutic use.

Authors:  Inge Bauer; Benedikt H J Pannen
Journal:  Crit Care       Date:  2009-08-14       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.